Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics

Shokouh Arjmand; Mats B. Lindström; Carl M. Sellgren; Gregers Wegener

doi:10.1192/j.eurpsy.2025.14

Accepted manuscript

Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics

Published online by Cambridge University Press: 05 February 2025

Carl M. Sellgren and

Shokouh Arjmand*: Affiliation:
Department of Pharmacology and Physiology, Karolinska Institutet, Stockholm, Sweden Translational Neuropsychiatry Unit, Aarhus University, Aarhus, Denmark
Mats B. Lindström: Affiliation:
Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden
Carl M. Sellgren: Affiliation:
Department of Pharmacology and Physiology, Karolinska Institutet, Stockholm, Sweden Centre for Psychiatry Research, Department of Clinical Neuroscience, Stockholm Health Care Services, Karolinska Institutet, and Stockholm Health Care Services, Stockholm, Sweden
Gregers Wegener: Affiliation:
Translational Neuropsychiatry Unit, Aarhus University, Aarhus, Denmark Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark
*: Corresponding author: Correspondence to: Shokouh Arjmand, C3 Fysiologi och farmakologi, C3 FyFa Cellulär modellering av psykiatriska sjukdomar, 171 77 Stockholm, Sweden (shokouh.arjmand@ki.se)

Article contents

Abstract

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Viewpoint
Information: European Psychiatry , Accepted manuscript , pp. 1 - 5

DOI: https://doi.org/10.1192/j.eurpsy.2025.14 [Opens in a new window]
Creative Commons: This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.